Compare ONC & MDLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ONC | MDLN |
|---|---|---|
| Founded | 2010 | 1966 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.8B | 37.1B |
| IPO Year | N/A | N/A |
| Metric | ONC | MDLN |
|---|---|---|
| Price | $317.89 | $47.55 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 23 |
| Target Price | ★ $377.33 | $49.74 |
| AVG Volume (30 Days) | 234.7K | ★ 2.5M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $770.07 | $9.62 |
| Revenue Next Year | $15.48 | $7.53 |
| P/E Ratio | ★ $614.06 | $658.75 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $196.53 | $38.50 |
| 52 Week High | $385.22 | $50.88 |
| Indicator | ONC | MDLN |
|---|---|---|
| Relative Strength Index (RSI) | 35.71 | 54.14 |
| Support Level | $307.93 | $43.04 |
| Resistance Level | $350.56 | N/A |
| Average True Range (ATR) | 10.46 | 1.94 |
| MACD | -4.21 | 0.06 |
| Stochastic Oscillator | 6.49 | 54.06 |
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.
Medline Inc provides medical-surgical products and supply chain solutions for various healthcare settings. Its offerings include med-surg products, including surgical and procedural kits, gloves and protective apparel, urological and incontinence care, wound care, and consumable lab and diagnostics products. It serves hospitals, surgery centers, physician offices, and post-acute care facilities, supporting patient care needs. The company operates in two segments: Medline Brand and Supply Chain Solutions. The company's revenues are generated principally from the sale of its surgical products.